Salmonella regulation of intestinal stem cells through the Wnt/β-catenin pathway  by Liu, Xingyin et al.
FEBS Letters 584 (2010) 911–916journal homepage: www.FEBSLetters .orgSalmonella regulation of intestinal stem cells through the Wnt/b-catenin pathway
Xingyin Liu a, Rong Lu a, Shaoping Wu a, Jun Sun a,b,*
aDepartment of Medicine, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
bDepartment of Microbiology and Immunology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
a r t i c l e i n f oArticle history:
Received 16 November 2009
Revised 7 January 2010
Accepted 14 January 2010
Available online 19 January 2010
Edited by Lukas Huber
Keywords:
Stem cell
Wnt
b-Catenin
AvrA
Proliferation
Type three secretion system
Bacterial effector
Salmonella0014-5793/$36.00  2010 Federation of European Bio
doi:10.1016/j.febslet.2010.01.024
* Corresponding author. Address: Department of Me
Rochester, 601 Elmwood Avenue, Rochester, NY 14642
E-mail address: jun_sun@urmc.rochester.edu (J. Sua b s t r a c t
Recent studies have revealed that bacteria target stem cells for long-term survival in a Drosophila
model. However, in mammalian models, little is known about bacterial infection and intestinal
stem cells. Our study aims at understanding bacterial regulation of the intestinal stem cell in a Sal-
monella colitis mouse model. We found that Salmonella activates the Wnt/b-catenin signaling path-
way that is known to regulate stem cells. We identiﬁed Salmonella protein AvrA that modulates Wnt
signaling including upregulating Wnt expression, modifying b-catenin, increasing total b-catenin
expression, and activating Wnt/b-catenin transcriptional activity in the intestinal epithelial cells.
The numbers of stem cells and proliferative cells increased in the intestine infected with Salmonella
expressing AvrA. Our study provides insights into bacterial infection and stem cell maintenance.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Enteric bacteria manipulate the pathways critical for the im-
mune response and host defenses. Recently, studies in Drosophila
demonstrate that gut homeostasis is maintained through a balance
between cell damage due to the collateral effects of bacteria killing
and epithelial repair by stem cell division [1,2,25]. Global gene
expression analysis of Drosophila intestinal tissue with bacterium
Erwinia carotovora infection revealed that immune responses in
the gut are regulated by the Imd and JAK-STAT pathways. The
ingestion of bacteria had a dramatic impact on the physiology of
the gut, including the modulation of stress response and increased
stem cell proliferation and epithelial renewal [1,2]. Although the
Drosophila gut provides a powerful model to study the integration
of stress and immunity with pathways associated with stem cell
control, little is known in the mammalian models of bacterial
infection and intestinal stem cells. Due to the complexity of the
intestinal gut ﬂora, the identiﬁcation of the speciﬁc microbial
agents that contribute to stem cell signaling remains challenging.
In the mammalian intestine, crypts and villi form the funda-
mental repetitive unit of the tissue. The crypt is a proliferative
compartment which is composed of 250–300 cells that are inchemical Societies. Published by E
dicine, Box 646, University of
, USA. Fax: +1 585 275 8118.
n).constant active proliferation; it also generates all of the cells
required to renew the entire intestinal epithelium in mice in
2–3 days. Therefore, the intestine is one of the best models for
studying adult stem cells in vivo [3]. Stem cells in the intestine
are regulated by Wnt signaling. The Wnt gene family consists of
19 members in mammals. These family members are implicated
in the regulation of a wide variety of normal and pathological pro-
cesses, including embryogenesis, differentiation, and carcinogene-
sis [4,5]. The canonical Wnt pathway regulates the upstream
portion of the b-catenin pathway [6,7]. Without Wnt, b-catenin is
constitutively degraded. When Wnt ligands are bound to the
Frizzled/LRP co-receptor complex, b-catenin is stabilized and
activated. Beta-catenin translocates to the nucleus, where it binds
Tcf transcription factors, thus activating Wnt target genes [8,9].
AvrA is a newly described bacterial effector present in 80% of
Salmonella enterica serovar [10,11] and E. coli [12]. It is transferred
into host cells through the type three secretion system, a bacterial
needle-like apparatus [10]. AvrA regulates b-catenin ubiquitination
and stabilizes b-catenin [13–17], a key regulator of intestinal epi-
thelial proliferation. Previously, we demonstrated that bacteria
activate the b-catenin pathway [14,16]. Because b-catenin is at
the downstream end of the Wnt pathway, we reason that patho-
genic Salmonella modulate the intestinal stem cells and that AvrA
activates stem cell niches through the Wnt pathway. In present
study, we found that Salmonella infection activates signaling path-
ways related to stem cells in vivo. We have also found that AvrAlsevier B.V. All rights reserved.
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fected mice. AvrA activates Wnt signaling at multiple levels,
including upregulating Wnt mRNA expression, increasing total b-
catenin expression, and activating Wnt/b-catenin transcriptional
activity in the intestinal epithelial cells. The number of stem cells
and proliferative cells increased in the intestine infected with Sal-
monella expressing AvrA. Our results provide insights into bacterial
infection and intestinal stem cell niches.
2. Materials and methods
2.1. Bacterial strains and growth conditions
Bacterial strains include Salmonella typhimurium 1344, SB1117
[10], S. typhimurium mutants PhoPc, PhoPc AvrA and PhoPc
AvrA/AvrA+ [15]. Bacterial growth conditions were as follows:
non-agitated microaerophilic bacterial cultures were prepared by
inoculating 10 ml of Luria–Bertani broth with 0.01 ml of a station-
ary phase culture, followed by overnight incubation (18 h) at
37 C, as previously described [18].
2.2. Streptomycin pre-treated mouse model
Animal experiments were performed using speciﬁc-pathogen-
free female C57BL/6 mice (Taconic, Hudson, NY) that were 6–
7 weeks old. The protocol was approved by the University of
Rochester University Committee on Animal Resources. Water and
food were withdrawn 4 h before oral gavage with 7.5 mg of strep-
tomycin per mouse. Mice were infected with 1  107 CFU of S.
typhimurium (100 ll suspension in HBSS) or treated with sterile
HBSS (control) by oral gavage as previously described [15,17]. At
6 or 18 h, or 4 days after infection, mice were sacriﬁced and tissue
samples from the intestinal tracts were removed for analysis.
2.3. Immunoblotting
Mouse epithelial cells were scraped and lysed in lysis buffer (1%
Triton X-100, 150 mM NaCl, 10 mM Tris (pH 7.4), 1 mM EDTA,
1 mM EGTA (pH 8.0), 0.2 mM sodium ortho-vanadate, protease
inhibitor cocktail), and the protein concentration was measured.
Equal amounts of proteins were separated by SDS–polyacrylamide
gel electrophoresis, transferred to nitrocellulose, and immunoblot-
ted with antibodies as previously described [15,17].
2.4. Real-time quantitative PCR analysis
Total mRNA was extracted from scraped mouse colonic epithe-
lial cells using TRIzol reagent (Invitrogen, Carlsbad, CA) and reverse
transcribed using the SuperScript™ III ﬁrst-strand synthesis kit
(Invitrogen). cDNA was then subjected to real-time PCR (SYBR
Green PCR kit, BioRad) with primers (Table 1). Percent expression
was calculated as the ratio of the normalized value of each sampleTable 1
Primers for real-time PCR.
Name Sequences of primers Length of PCR (bp)
Wnt3 Fw 5-GTC TGC TAA TGC TGG CTT GAC-3 146
Wnt3 Rv 5-TAG GAA GGG ATG GGA GGT GT-3
Wnt6 Fw 5-TTT ACA CCA GCC CAC GAA AG-3 162
Wnt6 Rv 5-ACT CAC CCA TCC ATC CCA GTA-3
Wnt9a Fw 5-ATG GTG TGT CTG GCT CCT G-3 132
Wnt9a Rv 5-CAG TGG CTT CAT TGG TAG TGC T-3
TCF-4 Fw 5-GGACGGACAAAGAGCTGAGTG-3 208
TCF-4 Rv 5-ATGTGGTCATAGGGAGTCCCA-3
Actin Fw 5-TGTTACCAACTGGGACGACA-3 139
Actin Rv 5-CTGGGTCATCTTTTCACGGT-3relative to that of the corresponding untreated control cells. All
real-time PCR reactions were performed in triplicate.
2.5. Wnt transcriptional activity assay
The activity of the Wnt/b-catenin signal transduction pathway
was measured using the Cignal TCF/LEF Reporter Assay (SABio-
sciences, Frederick, MD). Brieﬂy, human intestinal cancer cell line
HCT1116 was co-transfected with an inducible TCF/LEF-responsive
ﬁreﬂy luciferase reporter or a non-inducible ﬁreﬂy luciferase re-
porter as a negative control, as well as speciﬁc pCMV–AvrA or
pCMV. LiCl treatment (30 nM for 24 h after transfection) was used
as the positive control. Luciferase activity was monitored using the
dual luciferase assay system (Promega, Madison, WI). Experiments
were done in triplicate with three repeats.
2.6. Immunohistochemistry
Tissues were ﬁxed and processed the next day by standard tech-
niques, as previously described [15]. The number of proliferating
cells was detected by immunoperoxidase staining for the thymi-
dine analog, bromodeoxyuridine (BrdU). Animals were injected
with 5-bromo-20-deoxyuridine (100 mg/kg; Sigma, St. Louise, MO,
USA), i.p., 2 h before sacriﬁce. Specimens were ﬁxed in 10% buffered
formalin and handled as previously described [15]. The slides were
stained with anti-BrdU, anti-Bmi 1 (Abcam, Cambridge, MA, USA),
or anti-p-b-catenin (ser 552) (Cell Signal, Beverly, MA) antibodies.
2.7. Immunoﬂuorescence
Intestinal tissues were freshly isolated and embedded in paraf-
ﬁn wax after ﬁxation with 10% neutral buffered formalin. Tissue
samples or cultured cells were processed for immunoﬂuorescence
as described previously [17]. The slides were stained with anti-
Lgr5 (Abcam), anti-Jagged1, anti-Salmonella lipopolysaccharide
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) antibodies.
Cells or tissues were mounted with SlowFade (SlowFade AntiFade
Kit, Molecular Probes) followed by a coverslip, and the edges were
sealed to prevent drying. Specimens were examined with a Leica
SP5 Laser Scanning confocal microscope.
2.8. Statistical analysis
Data are expressed as the mean ± S.D. Differences were ana-
lyzed by the Student’s t-test. P-values <0.05 were considered sta-
tistically signiﬁcant.3. Results
3.1. Bacterial infection alters Wnt expression and stem cell markers
Wnt3, Wnt6, and Wnt9A are known to regulate intestinal stem
cells [5]. Using a Salmonella colitis mouse model, we assessed Wnt
mRNA expression before and after Salmonella infection. The mRNA
levels of Wnt3, 6, and 9a were signiﬁcantly upregulated in the
intestinal epithelial cells by Salmonella (Fig. 1A). Our immunostain-
ing data of Igr5, an intestinal stem cell marker, showed the location
of the stem cells at the base of the crypts in Salmonella-infected
mouse intestines (Fig. 1B). We also detected the location of the
stem cell marker, Bmi1, which was induced by Salmonella
(Fig. 1C). Moreover, Wnt and Notch pathways work together [5]
and Jagged 1 is a link is between Wnt and Notch pathways in-
volved in cell-fate decisions [19,20]. We found that the majority
of Jagged 1 located at the bottom of the crypts of the small intes-
tine. However, after Salmonella infection, Jagged 1 was found to
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Fig. 1. Salmonella infection involves Wnt signaling and stem cells. (A) Wnt3, Wnt6, and Wnt 9A mRNA expression in intestinal epithelial cells post-Salmonella infection.
*P < 0.05; **P < 0.01. (B and C) Lgr5 and Bmi1 localization in the Salmonella infected intestine. (D) Relocation of Jagged 1 in the mouse intestine 4 days post-Salmonella
infection.
X. Liu et al. / FEBS Letters 584 (2010) 911–916 913be translocated and diffusely distributed in the crypts (Fig. 1D). Ta-
ken together, these data indicate that Salmonella infection induces
a dynamic change in the stem cells.
3.2. Salmonella AvrA modulates phosphorylated-b-catenin and
increases total b-catenin expression
Previous studies have demonstrated that Salmonella AvrA stabi-
lizes b-catenin [13–17]. Because b-catenin is at the downstreamend of the Wnt pathway, we reasoned that AvrA activates stem cell
niches through the Wnt pathway. Phosphorylated-b-catenin (ser
552) is another stem cell marker [21], so we tested whether AvrA
changes phosphorylated-b-catenin expression. We found that
phosphorylated-b-catenin (ser 552) is decreased by infection with
an AvrA-deﬁcient bacterial strain (AvrA), but not by bacterial
strains expressing AvrA in vivo (Fig. 2A PhoPc and AvrA+/). We
also assessed the total amount of b-catenin present in mice after
infection. Salmonella PhoPc with AvrA expression increased the
 PhoPC
β-actin
 Salmonolla PhoPC
AvrA- AvrA-/AvrA+
β-catenin 
Control
 PhoPC
 Salmonolla PhoPC
AvrA-Control
β-catenin 
Villin
p-β-catenin 
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Fig. 2. Bacterial protein, AvrA, regulates b-catenin protein expression in intestinal
cells in vivo. Mice were infected with S. typhimurium PhoPC, PhoPC/AvrA (AvrA
gene mutant), or PhoPC/AvrA/AvrA+ (AvrA gene restored). Colonic epithelial cells
were scraped, and total cell lysates were analyzed for phosphorylated-b-catenin
(ser 552) levels by immunoblotting. (A) AvrA modulated the stem cell marker
phosphorylated-b-catenin (ser 552) expression in intestinal epithelial cells. Villin is
an epithelial cell marker. (B) AvrA in Salmonella increased the total b-catenin
expression in intestinal epithelial cells.
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Fig. 3. Location of phosphorylated-b-catenin (ser 552) in the Salmonella-infected
mouse intestine. (A) Immunohistochemical staining of phosphorylated-b-catenin in
the Salmonella-infected intestine. (B) Numbers of phosphorylated-b-catenin (ser
552) positively stained cells in the normal and Salmonella-infected intestines. (C)
Distribution of Salmonella (green) in mouse colon 4 days post infection.
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presence of PhoPc AvrA (lacking AvrA expression) bacteria,
whereas b-catenin was stabilized in the presence of PhoPc AvrA/
AvrA+ bacteria (Fig. 2B).
3.3. Location of phosphorylated-b-catenin (ser 552) in the Salmonella
infected intestine
We also investigated the location of p-b-catenin (ser 552) in the
normal and Salmonella-infected intestine (Fig. 3A). The p-b-catenin
(ser 552) was located in the nuclei of cells located at the bottom of
crypts, i.e., the stem cell niches. We also tested whether infection
with the Salmonella strain with AvrA expression changes the num-
ber of phosphorylated-b-catenin positive staining cells. Our data
showed that the number of cells with positive p-b-catenin (ser
552) staining signiﬁcantly increased in the Salmonella-infected
intestine compared to that in the normal intestine without any
bacterial treatment (Fig. 3B). A concern for the in vivo study is
the bacterial colonization ability in the intestinal epithelial cells.
To address the location by which S. typhimurium infects the
intestine, we stained infected colon tissues for Salmonella lipopoly-
saccharide by immunoﬂuorescence. S typhimurium bacteria were
found in the intestine 4 days post infection (Fig. 3C). This localiza-
tion indicates the persistence of Salmonella infection in mouse
intestine.
3.4. AvrA expression activates the Wnt pathway
We further investigated Wnt/b-catenin transcriptional activity
in activity in a human intestinal cancer cell line HCT1116 colonized
by Salmonella. We found that bacterial protein AvrA was able to
signiﬁcantly increase the Wnt/b-catenin transcriptional activity
(Fig. 4A). LiCl treatment, which activates the Wnt/b-catenin path-
way, was used as a positive control. Upon Wnt activation, b-cate-
nin became stabilized and translocated to the nuclei binding
with T cell factors (TCF). In addition, Salmonella colonization of
the HCT1116 cells increased TCF 4 at the mRNA level (Fig. 4B).
These results suggest that AvrA activates the Wnt/b-catenin path-
way, thus regulating intestinal stem cells.3.5. AvrA increases small intestinal epithelial cell proliferation in vivo
While examining changes in stem cell marker expression in-
duced by bacterial colonization, we also examined the effect of
AvrA on intestinal epithelial cell proliferation, which is regulated
by the Wnt/b-catenin pathway. BrdU staining was performed to
measure BrdU incorporation into newly synthesized DNA. BrdU-
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induced a dramatic decrease in epithelial cell proliferation
(Fig. 5), whereas the strain SL1344 (SB300) with AvrA expression
signiﬁcantly increased cell proliferation (Fig. 5). Please note that
the proliferating cells are located at the bottom of the small intes-
tinal crypts (identiﬁed by a pathologist). The number of proliferat-
ing cells per intestinal gland further demonstrated that AvrA
increased intestinal epithelial cell proliferation in vivo (Fig. 5B).
4. Discussion
In the present study, we report that enteric Salmonella infection
modulates intestinal stem cells and that Salmonella protein AvrA
activates stem cell niches through the Wnt pathway. AvrA in-
creases Wnt mRNA expression, b-catenin modiﬁcation, total b-
catenin expression, transcriptional activity, and stem cell markers
in the intestinal epithelial cells. There was less epithelial cell pro-
liferation in cells infected by AvrA Salmonella and greater cell pro-
liferation in colons infected by Salmonella with sufﬁcient AvrA
expression. Whereas intestinal stem cells have been intensively
studied, the role of bacteria in modulating intestinal stem cell sig-
naling has not been well established. Our ﬁndings provide impor-
tant insights into how a bacterial protein contributes to the
activation of the Wnt pathway and the maintenance of intestinal
stem cells.
Currently, most stem cells studies use knock-in or transgenic
models. The estimated number of pluripotent stem cells is about
30 cells/crypt [3]. We understand the challenge of working on nor-
mal mice. The modiﬁcation of stem cell numbers and distribution
requires close monitoring at different time points post-infection.
We used multiple stem cell markers and assays to identify thestem cells and study their locations, number, and proliferation
capacity and how those properties were affected by Salmonella.
We found that AvrA contributes to the upregulation of the stem
cell marker, p-b-catenin (ser 552). However, Lgr5 protein expres-
sion did not change during the early stage of Salmonella infection
(8 h post-infection). In contrast, at 4 days post-infection, there
was a signiﬁcant reduction of Lgr5 protein expression in the Salmo-
nella-infected small intestine (data not shown). These results indi-
cate that Salmonella infection dynamic changes the number of the
stem cells during the different stages of infection. Previous studies
[14,15] and our current results demonstrate that AvrA increases
intestinal epithelial cell proliferation. Whereas bacterial infection
induces the epithelial loss, AvrA constitutes to maintenance of
the intestinal epithelia. Further investigation is needed to clarify
AvrA’s role on the stem cell renewal, differentiation, and
proliferation.
Activation of b-catenin pathway initiates the neoplastic process,
resulting in intestinal adenomas. These tumors progress as muta-
tions in genes, such as p53, accumulate [22]. P53 plays role in both
cancer and stem cell growth [23]. Our unpublished data showed
that p53 pathway is activated by Salmonella infection in vivo. AvrA
is a multi-functional protein that inﬂuences eukaryotic cell path-
ways that utilize phosphorylation, ubiquitination, and acetylation
[12,15,24]. Assessing other pathways, such as the JNK, JAK-STAT,
and p53 pathways, will further elucidate the role of AvrA on stem
cells in tumor progression.
In summary, we ﬁnd that pathogenic Salmonella infection mod-
ulates intestinal stem cells and the Salmonella protein, AvrA, acti-
vates stem cell niches through the Wnt pathway. Our long-range
goal is to elucidate the role of enteric bacteria in the development
of colitis and cancer through their modulation of intestinal stem
cells.
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